Pictured: Illustration of a base nucleotide being replaced out of DNA/iStock, Rasi Bhadramani Beam Therapeutics on Tuesday announced it had dosed its first patient in the Phase I/II clinical trial of BEAM-201, an investigational allogeneic quadruplex-edited allogeneic...
Moderna and China’s CARsgen Therapeutics have joined forces to merge their expertise in the cancer treatment arena. The collaboration seeks to test the combined efficacy of Moderna’s experimental Claudin18.2 mRNA cancer vaccine and CARsgen’s Claudin18.2 CAR T cell...